Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Ocular Therapeutix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
Venrock Healthcare Capital Partners III L.P. | 13,760,200 8.700% |
5,984,440 (+76.96%) |
Filing |
| 2023-12-28 4:17 pm Purchase |
2023-12-18 | 13G | Ocular Therapeutix, Inc. OCUL |
Venrock Healthcare Capital Partners III L.P. | 7,775,760 6.800% |
7,775,760 (New Position) |
Filing |